Summary:
A study to evaluate the tolerability of an investigational medication in patients with non-alcoholic steatohepatitis (liver inflammation & damage caused by a build up of fat in the liver).
Qualified Participants Must:
• 18-75 years of age, inclusive
•
Have a diagnosis of non-alcoholic steatohepatitis (liver inflammation & damage caused by a build up of fat in the liver)
•
Additional qualification criteria exist
Qualified Participants May Receive:
- Reimbursement available for time and travel
- Study-related care and study medicine at no cost (no health insurance required)